Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
FDA lifts clinical hold on combined COVID-19-influenza vaccine trials
